A previous study demonstrated that the mRNA and protein levels of COL3A1 are not only present in colorectal cancer (CRC) cells, but also increased in the plasma of CRC patients, which is associated with clinicopathologic factors and poor survival [24]. The gene discussed is COL3A1; the disease is colorectal cancer.